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To study the evolution of dengue virus (DENV) sero-
type 2 in Puerto Rico, we examined the genetic composition 
and diversity of 160 DENV-2 genomes obtained through 22 
consecutive years of sampling. A clade replacement took 
place in 1994–1997 during a period of high incidence of 
autochthonous DENV-2 and frequent, short-lived reintro-
ductions of foreign DENV-2. This unique clade replacement 
was complete just before DENV-3 emerged. By temporally 
and geographically deﬁ  ning DENV-2 lineages, we describe 
a refuge of this virus through 4 years of low genome di-
versity. Our analyses may explain the long-term endurance 
of DENV-2 despite great epidemiologic changes in disease 
incidence and serotype distribution.
E
pidemic dengue fever (DF) and the emergence of den-
gue hemorrhagic fever (DHF) in the Americas are as-
sociated with increased endemicity and cocirculation of the 
4 dengue virus (DENV) serotypes, 1–4 (1). These increases 
have been particularly evident in Puerto Rico, where trans-
mission increased during the past 25 years (2–4). The ﬁ  rst 
DHF epidemics in the Americas occurred in the 1980s and 
were caused by the Asian/American genotype of DENV-2, 
then new to the region, which rapidly replaced the Ameri-
can genotype (5–7). This replacement has been linked to a 
potential to cause higher viremia and severe illness (8–10). 
Introduction of DENV-3 in the mid 1990s and increased hu-
man population and travel further fostered larger and more 
frequent DF and DHF epidemics in the region (11–13).
Although all 4 DENV serotypes circulate on the island, 
DENV-2 circulated continuously for 25 years. Previously, 
a partial sequence analysis from 74 DENV-2 isolates col-
lected in Puerto Rico during 7 years throughout a 14-year 
period (1987–2001) showed a DENV-2 lineage evolving 
through a series of turnover events (14). A lineage replace-
ment in 1994 appeared to be associated with a foreign virus 
but only 3 other reintroductions were found, all linked to 
the 1998 epidemic, the largest in Puerto Rico history (14). 
This was a turning point in the epidemiology of dengue, 
with DENV-2 (and DENV-1 and -4) rapidly declining dur-
ing the expansion of DENV-3. However, transmission of 
DENV-2 persisted at low levels during 1999–2003 and in-
creased thereafter. This serotype turnover offers new op-
portunities to study the evolution of DENV-2. Our analysis 
illustrates the genetic composition and population diversity 
of DENV-2 throughout 22 consecutive years of sampling 
in Puerto Rico and may explain the evolutionary resilience 
and long-term establishment of this virus.
Methods
Virus Isolates
We complied with the institutional review boards of 
the Centers for Disease Control and Prevention (CDC) 
(protocol 4797) and the Broad Institute of MIT and Har-
vard. DENV was obtained from human serum received 
through the passive surveillance system administered by 
CDC. Each sample was accompanied by a form that cap-
tured geographic and clinical information maintained for 
this study without patient identiﬁ  ers. Primary or secondary 
status of infection was inferred by absence or presence of 
serum immunoglobulin G (15). Viruses were rescued into 
C6/36 cells (16). Selection of 3 isolates per year in the 5 
municipalities with the highest reporting of DENV-2 cases 
resulted in 253 isolates, of which 140 were successfully se-
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quenced and are representative of our virus repository with 
respect to patient age (27.7 vs. 22.6 years), sex (54.4% vs. 
47.4% male), and history of infection (84.6% vs. 77% sec-
ondary infections). We also sequenced 20 regional isolates 
from neighboring countries.
Sequencing
We extracted RNA from tissue culture supernatant us-
ing the M48 or MDx BioRobot (QIAGEN, Valencia, CA, 
USA). cDNA was generated by using Sensiscript RT (QIA-
GEN) with random hexamers (Applied Biosciences, Fos-
ter City, CA, USA). Presence of cDNA was conﬁ  rmed by 
PCR by using PfuUltraII (Stratagene, La Jolla, CA, USA) 
or iTaq (Bio-Rad, Hercules, CA, USA) DNA polymerase 
and speciﬁ  c oligonucleotides (CDC, Atlanta, GA, USA). 
Fourteen pooled overlapping 2,000 nt amplicons were gen-
erated by reverse transcription–PCR at CDC (San Juan, 
PR) and sequenced at the Broad Institute (Cambridge, MA, 
USA) by bidirectional Sanger by using an ABI 3730 after 
PCR with 96 M13-tailed serotype-speciﬁ  c primers. Result-
ing reads were trimmed of the primer sequences, ﬁ  ltered 
for high quality, and assembled by using algorithms devel-
oped by the Broad Institute. All coding sequences for the 
poliproteins (10,173 nt) and parts of the 5′ and 3′ noncoding 
regions were deposited in GenBank.
Sequence Analyses
Coding sequences for the unprocessed polyprotein (5′ 
and 3′ noncoding regions excluded) were aligned by Clust-
alW software (www.ebi.ac.uk/Tools/clustalw/index.html) in 
MEGA 4 (www.megasoftware.net). Maximum-likelihood 
analysis and bootstrapping tests were performed in PAUP* 
(16) under the best-ﬁ   t substitution model estimated by 
MODELTEST v3.07 (14) (parameters available on request). 
The 1983 Jamaican isolate JM_83_M20558 (5) served as 
outgroup. Mean rates of nucleotide substitution and relative 
genetic diversity (Net, where t is the generation time) were 
estimated by using Bayesian Markov Chain Monte Carlo 
(MCMC) from BEAST v1.4.7 (http://mbe.oxfordjournals.
org/content/25/7/1459). General time reversible substitution 
model with strict and relaxed molecular clocks and constant 
population size or Bayesian Skyline coalescent analysis was 
used. All MCMC chains were run for sufﬁ  cient length en-
suring stationary parameters, with statistical error reﬂ  ected 
in values of the 95% highest probability density. Amino 
acid differences were mapped by using parsimony methods 
in MacClade v4.08 (17). We determined dN/dS ratios with 
the single likelihood ancestor counting method using HY-
PHY and accessed through the Datamonkey server (13). 
Associations between phylogeny and geographic data were 
investigated by using Bayesian Tip-association Signiﬁ  cance 
testing (http://evolve.zoo.ox.ac.uk/evolve/BaTS.html) with 
the posterior sample of trees calculated by BEAST. For the 
parsimony score, association index, and monophyletic clade 
size, we considered p<0.05 signiﬁ  cant.
Results
During 1986–2007, dengue cases in Puerto Rico 
ranged from 2,000 to ≈16,000 per year (Figure 1, panel 
A), with major epidemics (>8,000 cases) reported in 1986, 
1992, 1994, 1998, and 2007 (2–4,18,19). Despite major 
ﬂ   uctuations in serotype circulation, DENV-2 circulated 
predominantly for 10 years (Figure 1, panel B), alternating 
with DENV-1 through 2 periods of resurgence during the 
1990s and cocirculation of DENV-4 (Figure 1, panel B). 
DENV-2 declined markedly after the 1998 epidemic and 
the dissemination of DENV-3 concomitant to the disap-
pearance of DENV-1 and -4. However, DENV-2 continued 
to cause a low number of cases during 1999–2003 and re-
emerged in 2004–2007 (Figure 1, panel B). Samples from 
every year of the 22-year study period (Figure 1, panel C) 
comprised our analysis.
The Bayesian Skyline analysis (Figure 1, panel D) 
of the autochthonous viral sequences (Figure 2; clades IB 
and II in the online Appendix Figure, www.cdc.gov/EID/
content/17/1/64-appF.htm) showed a gradual increase in 
the genetic diversity of DENV-2 during 1987–1991 that 
corresponds to a period of high transmission and domi-
nance (Figure 1, panel B). This increase was followed by 
9 years of high genetic diversity that coincided with a pe-
riod of DENV-1 and DENV-4 cocirculation. The genetic 
diversity of DENV-2 declined sharply during 1999–2003, 
coinciding with a period of minimal DENV-2 transmission. 
Genetic diversity rebounded in 2005 to roughly pre-1999 
levels as the virus reemerged.
The densely populated island of Puerto Rico (3,808,610 
population; 3,508 square miles) is divided into 78 munici-
palities grouped in 8 regions. The 140 DENV-2 genomes 
from 37 municipalities represented all 8 regions and ranged 
from 2–20 isolates per year (Figure 1, panel C; Figure 2). 
We included 20 other sequences from Caribbean countries. 
The number of Puerto Rico sequences is proportional to the 
epidemic level or the relative proportion of DENV-2 identi-
ﬁ  cations in the municipalities with highest DENV-2 report-
ing per year. The phylogeny of the 160 DENV-2 genomes 
showed 2 major clades (I and II) and a smaller clade (III) 
(Figure 2). Clade I contains 115 sequences and can be further 
subdivided in 2 subclades. Subclade IA (1998–2007) con-
tains 13 Puerto Rico and 12 Caribbean sequences, including 
1 from St. Thomas (SH 90 FJ898450) identiﬁ  ed as the clos-
est ancestor. Subclade IB (1994–2007) contains 90 sequenc-
es mostly of local origin, but the presence of 6 foreign and 
1 local basal sequences conﬁ  rms its foreign origin. Clade II 
(1986–1994) contains 39 local isolates. Basal to clades I and 
II is a St. John 1987 sequence (SJ 87 GQ868603), which sug-
gests a possible origin. Clade III is formed by 4 local isolates 
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during1987–1991. These genetically distinct isolates do 
not ﬁ  t in clade I or II, but a separate analysis with publi-
cally available envelope gene sequences pointed to possible 
Caribbean origin (K.L. McElroy et al., unpub. data).
Four events merit recognition (Figure 2). First, a mix-
ture of foreign and local strains at the base of subclades 
IA and IB provides evidence of multiple introductions. 
Eight Puerto Rico viruses associated with these foreign 
strains date from 1994 through 1999. These years also are 
associated with a distinct subgroup basal to subclade IB 
concomitant with the extinction of clade II in 1997. Sec-
ond, subclade IB evolved mainly after the introduction of 
DENV-3 in 1998. Third, a period of limited circulation of 
DENV-2 reﬂ  ected in low levels of genetic diversity (1999–
2003) coincided with the expansion of DENV-3 and de-
cline of DENV-1 and -4. Fourth, there was a resurgence of 
DENV-2 during 2004–2007.
Forty-nine amino acid differences mapped to the phy-
logeny were detected across the major internal branches of 
the tree. Twenty of these comprise major differences be-
tween clades I and II and between subclades IA and IB, 
as well as substitutions that arose during the continuous 
evolution of subclade IB (Figure 2). Only 1 aa substitu-
tion distinguished isolates in clades I/II from III: a hydro-
philic glutamine to a hydrophobic leucine at position 131 
in the E protein. Excluding PR79_1995_EU569708 as a 
possible foreign introduction, 18 aa differences distinguish 
isolates across clade I, 12 of which separate subclade IB 
from clade II and potentially could have been involved in 
the 1994–1997 lineage turnover (Figure 2). The remaining 
differences between isolates in subclades IB and II were 
present in nonstructural (NS) genes and are preponderantly 
conservative mutations, with the exception of position 31 
in NS3, which was nonconservative. Among the additional 
changes, the only nonconservative mutation was a hydro-
phobic alanine to hydrophilic threonine at position 137 in 
NS4B that originated with PR40_1999 EU482730, and 
most changes were found in the NS genes.
Using Bayesian MCMC and dN/dS analyses, we esti-
mated the mean substitution rates for the full genomes at 9 
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Figure 1. Historic overview of dengue, Puerto 
Rico, 1986–2007. A) Number of suspected, 
clinically deﬁ  ned cases of dengue fever/dengue 
hemorrhagic fever by year reported to the 
Centers for Disease Control and Prevention’s 
Dengue Branch. B) Percentage of identiﬁ  cations 
of each serotype relative to the total of positive 
serotype identiﬁ   cations by using tissue culture 
isolation or reverse transcription–PCR per year. 
Numbers in parenthesis indicate numbers of 
dengue virus (DENV) serotype 2 identiﬁ  cations 
each year. Black, DENV-1; blue, DENV-2; white, 
DENV-3; red, DENV-4. C) Number of partially 
sequenced (E gene) autochthonous Puerto Rican 
isolates reported by previous studies (14,20) 
and whole genome sequences obtained in the 
present study by year of their corresponding case 
presentation. D) Bayesian coalescent inference 
of population dynamics and genetic diversity by 
using the Bayesian Skyline plot. Markov Chain 
Monte Carlo from BEAST version 1.4.7 (www.
biomedcentral.com/1741-7007/8/114). Sampling 
procedures were used to estimate posterior 
distribution of DENV-2 genetic diversity in an 
effective population through the study period on 
the basis of full genome sequence data. x axis, 
time in years through the study period; y axis, 
product of the effective population size (relative 
genetic diversity) and generation length in years; 
black line, median estimate; blue shadow, 95% 
highest probability density.Dengue Virus Type 2, Puerto Rico
× 10–4 to 1.1 × 10–3 for all clades, consistent with previously 
published rates (20,21). The low dN/dS ratios (0.07–0.08) 
provide evidence of a low percentage of substitutions that 
have been ﬁ  xed along independent lineages, possibly indi-
cating purifying, negative selection.
BaTS analysis shows that lineages often correlated 
with the corresponding region of origin of the isolates. 
Seven of the 8 regions had >4 isolates in subclade IB or 
clade II. This association was signiﬁ   cant for 6 regions 
(p<0.05) (Table). The most signiﬁ  cant geographic correla-
tion of lineages were found in the San Juan (1986–1990 
and 1994–1996), Ponce (1987–1989), and Mayaguez 
(1989 and 1993) (Figure 3, panel A). In addition, isolates 
clustered geographically for San Juan (1997–1999 and 
2001–2006), Caguas (1998–2001, 2004, and 2005), Ponce 
(1995–1997 and 2005), Mayaguez (1996–1998 and 2006), 
Aguadilla (1996–1998), and Arecibo (1994–1995, 2004, 
and 2006) (Figure 3, panel B). Considering the DENV-2 
historical data, we recognize that high-reporting munici-
palities usually are located in regions where we identiﬁ  ed 
signiﬁ  cant phylogenetic clustering (online Appendix Fig-
ure). For example, in 1987, most DENV-2 cases originated 
from the Ponce and San Juan regions, where we identiﬁ  ed 
lineages of clade I. For1994–1996, DENV-2 cases in San 
Juan, Ponce, Mayaguez, and Arecibo regions may reﬂ  ect 
the coexistance of subclades IB and clade II.
We investigated other possible associations with the 
DENV-2 phylogeny, including age and DF/DHF status, 
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Figure 2. Evolution of dengue virus (DENV) 
serotype 2 in Puerto Rico. Maximum-likelihood 
phylogeny is shown for the 140 Puerto Rico 
and 20 international isolates of DENV-2 (see 
number of isolates by year below). Names of 
clades (I, II, and III) and subclades (IA, IB) are 
shown at the base of their respective branches 
on the phylogeny tree. Clade II (dark blue) 
circulated during 1986–1996 and clade I (light 
blue) during 1994–2007. Subclade IA and clade 
III represent foreign, transient reintroductions 
found throughout the 22-year study period. 
Black dots indicate 18 isolates from Puerto 
Rico with phylogenetic associations closer 
to foreign isolates than to other Puerto Rico 
viruses. Bootstrap values are shown for all 
clades (I, II, and II), subclades (IA, IB), and 
most immediate lineages. Twelve amino acid 
changes associated with IB/II differences 
are shown in the table, and 6 other selected 
changes across subclade IB are shown at 
the left at the base of the branches exhibiting 
the respective changes. Amino acid numbers 
refer to the position in each DENV protein. 
Relevant epidemiologic events are highlighted 
to the right with pie charts showing the relative 
levels of each serotype isolated for that period. 
Black, DENV-1; blue, DENV-2; white, DENV-3; 
red, DENV-4. GenBank accession numbers 
and geographic codes corresponding to all 
sequences are shown in an expanded online 
version of this ﬁ  gure  (www.cdc.gov/EID/
content/17/1/64-F2.htm). Scale bar indicates 
nucleotide substitutions per site.
Table. Correlation between phylogeny and geographic location of 




(95% HPD CIs) 
p value
I B  Aguadilla 5 2 (2–2)  0.04
Arecibo 12 3 (3–3)  0.03
Caguas 17 2.75  (2–3)  0.04
II Mayaguez 6 4  (4–4)  0.01
Ponce 11 3 (3–3)  0.05
San Juan  15 5 (5–5)  0.01
*Correlation estimated by using BaTs. Association index = 6.51 (95% CI 
6.03–7.22). Parsimony score statistic = 52.27 (95% CI 51–54). BaTs, 
Bayesian Tip-association Significance testing; HPD, highest probability 
density; CI, confidence interval. RESEARCH
but found none. Most DENV-2 infections were secondary 
(84.6% and 77% of DENV-2 infections in the CDC collec-
tion and this study, respectively). However, we found no 
relationship between phylogeny and incidence of primary 
or secondary infection in patients.
The year 1999 began a period of low circulation and 
low genetic diversity of the Caguas lineage of subclade IB 
(Figure 1, panel D; Figure 2; Figure 3, panel B) that lasted 
until 2003. During these 4 years, most DENV-2 cases orig-
inated from only 4 municipalities in eastern Puerto Rico 
(Figure 4, panel A); <20 additional DENV-2 cases were 
reported during that period in 12 other neighboring munici-
palities (Figure 4, panel A). Because phylogenetic lineages 
are geographically and temporally clustered, (Figure 2), 
we illustrated these associations on the map of Puerto Rico 
(Figure 4). This map shows that DENV-2 descendants from 
western Puerto Rico emerged in San Juan in 1997–1998 
(Figure 4, panel B, top), then appeared and persisted within 
the refuge in 1999–2002 (Figure 4, panel C, middle) to then 
disseminate across the island in 2003–2005 (Figure 4, pan-
el D). In the 4 municipalities with uninterrupted DENV-2 
transmission, DENV-2 incidence increased 2 years after the 
islandwide increase (Figure 5). DENV-3 incidence within 
this DENV-2 refuge was minimal during the period of high 
DENV-2 incidence but peaked 2 years later concomitant 
with an increase across the rest of the island
Discussion
Puerto Rico is a model for ﬁ  ne-scale studies on DENV 
evolution in the Americas. The long-term persistence of 
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Figure 3. Geographic clustering of Puerto Rico dengue virus lineages. A) Maximum-likelihood phylogeny of clade II. All isolates indicate 
year of case presentation and GenBank accession numbers. B) Maximum-likelihood phylogeny of subclade IB shows isolates by year 
and GenBank accession numbers. Six regions had >5 isolates (San Juan, Caguas, Ponce, Mayaguez, Aguadilla, and Arecibo). C) Eight 
regions of Puerto Rico with colors corresponding to isolates in panel A and year for the 3 regions with more isolates of that clade: San 
Juan, Mayaguez, and Ponce. D) Eight regions of Puerto Rico, showing colors and years corresponding to isolates in panel B. Correlation 
between phylogeny and geographic location of isolation for the isolates in this study was estimated by using Bayesian Tip-association 
Signiﬁ  cance testing. Association index 6.51 (95% conﬁ  dence interval 6.03–7.22); parsimony score statistic 52.27 (95% conﬁ  dence interval 
51–54). Monophyletic clade size Bayesian Tip-association Signiﬁ  cance estimates are shown for 6 regions of Puerto Rico with >5 isolates 
represented in at least 1 subclade and statistically representative geographic associations (p<0.05).Dengue Virus Type 2, Puerto Rico
DENV-2 and its ability to reemerge after transient periods 
of low circulation is a remarkable aspect of the epidemiol-
ogy of dengue in the region. The fact that 13% of DENV-2 
isolates represent importations or close descendants from 
importations brings new insights to our understanding of 
DENV long-term circulation. Foreign viruses were identi-
ﬁ  ed in 8 years (1987, 1989, 1991, 1995, 1998, 1999, 2005, 
and 2007), of which only 1991 and 1998 had been previ-
ously sampled (14). Ten of the 18 introductions occurred 
during periods of high DENV-2 predominance: 1987–1991, 
1995, and 2005–2007 (Figure 1, panel B; Figure 2). The 
other 8 introductions originated from the 1998 epidemic or 
shortly thereafter (1999). Therefore, DENV-2 seems to be 
introduced mainly during periods of favorable preponder-
ance, not necessarily epidemic transmission of this sero-
type. Subclade IA viruses never established themselves, 
regardless of year of isolation or origin. These assessments 
showed a previously unknown feature of DENV-2 persis-
tence: the endemic strain is recalcitrant to inﬂ  uences from 
frequent foreign introductions.
The relative inability of “foreign” DENV-2 to persist 
in the presence of the dominant subclade IB viruses is not 
well understood. The Puerto Rico strain might be highly 
adapted and thus have a ﬁ  tness advantage, the frequently 
introduced strains might be simply underrepresented, or 
introduced strains may have disappeared through genetic 
drift. Isolate PR76_1995_EU569708, which lies basal to 
this subclade in the phylogeny (Figure 2), is more closely 
related to South American DENV-2 viruses than to other 
Puerto Rico viruses, and this lineage does not appear to 
have progressed, supporting the foreign origin of subclade 
IB. Our ﬁ  ndings then show that subclade IB resulted from 
an introduced strain, as previously suggested by Bennett 
et al. (14), and successfully penetrated during a period of 
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Figure 4. Epidemiology of dengue virus (DENV) serotype 2 in Puerto Rico, 1997–2006. A) Municipalities with persistent DENV-2 transmission 
(Caguas, Juncos, Las Piedras, Carolina) versus those with discontinuous transmission (Morovis, Toa Alta, Toa Baja, Cataño, Guaynabo, 
Cidra, San Lorenzo, Canóvanas, Humacao, Naguabo, Ceiba, Fajardo), 1998–2002. Inset shows satellite view; red dot indicates national 
capital (San Juan), and yellow box indicates region where DENV-2 took refuge during 2000–2002. B–D) Satellite view depicts virus 
transmission corridors. White pins point to speciﬁ  c geographic locations where DENV-2 isolates were collected during the speciﬁ  ed time 
period. Yellow lines connect isolates by their phylogenetic afﬁ  liations suggesting migration of virus. B) DENV-2 traveled to the San Juan 
region from the west during 1997–1999; C) DENV-2 transmission retracted to the eastern, refuge region with restricted dispersion patterns 
during 2000–2002; D) DENV-2 reemerged focused on the San Juan region and later dispersed throughout the island during 2003–2006.RESEARCH
proportionally high incidence of foreign introductions. In-
terestingly, this clade replacement was completed in 1997, 
less than a year before the ﬁ  nding of DENV-3 and the con-
comitant decline of DENV-1, -2, and -4. The early portion 
of subclade IB is seen as a period of short-lived lineages 
ending in 1997, therefore, the rise and expansion of this 
subclade mainly occurs in coexistence with DENV-3, a dif-
ferent epidemiologic scenario from that of the now extinct 
clade II a decade earlier.
The dominance of conservative amino acid changes 
that segregated the viruses by clade hinders the assessment 
of phenotypic changes. Compensatory mutations might 
have conferred replicative advantages that could have in-
ﬂ  uenced the displacement of clade II or the persistence of 
subclade IB in Puerto Rico; however this hypothesis has 
not been tested. Positive selection was not identiﬁ  ed, con-
trasting with previous analyses (14,22–24). Others have not 
detected positive selection and attribute lineage extinctions 
or clade replacements to stochastic events rather than natu-
ral selection (25). More analysis to detect site-speciﬁ  c se-
lection is needed to corroborate whether positive selection 
is not at play in these populations of viruses.
The period 1999–2003 represents historically low rates 
of DENV-2 circulation (Figures 1, 2, 4), and the epidemio-
logic and phylogenetic aspects of this transient retrieval 
had not been studied previously. We show that the genet-
ic variability of DENV-2 decreased during these 4 years 
when the virus was transmitted in only a subset of munici-
palities. DENV-2 represented 29% of the cases in this area 
but only 5% island-wide. The reason this region became 
a refuge of DENV-2 for 4 years remains unclear, but the 
low incidence of DENV-2 in prior years compared with 
the rest of the island suggests susceptibility for infection 
in this population (Figure 5). Studies in Thailand showed 
serotype displacement affecting population diversity and 
lineage turnover (26). Short-term serotype cross-protection 
has been suggested to contribute to serotype displacements 
(27–29), implying that as DENV-3 infected a large suscep-
tible population, cross-protective antibodies momentarily 
impeded transmission of other serotypes and dissemination 
of DENV-2 outside the eastern refuge. Our study conﬁ  rms 
the utility of systematic sampling and genome sequencing 
in large-scale surveillance systems as ways to understand 
the dynamics of dengue transmission and endemicity.
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